The original version of PR Newswire is available at: www.prnewswire.com/news-releases/abbvie-completes-acquisition-of-pharmacyclics-30008494.html Free copies of the exchange documents (including the registration statement and schedule TO) are also available on abbVie`s website under www.abbvieinvestor.com and copies of Schedule 14D-9 are available on the Pharmacyclics www.pharmacyclics.com website. Copies of the exchange documents (including the registration declaration and schedule TO) can also be obtained free of charge from Georgeson Inc., the information agent for the exchange offer, by telephone, toll-free, (888) 680-1528 or by e-mail PCYC@georgeson.com. AbbVie will acquire all of the outstanding common shares of Pharmacyclics in a takeover bid, followed by a merger in a second step. . . .
Posted in: UncategorizedLeave a Comment (0) ↓